COLLEGIUM PHARMACEUTICAL, INC·4

Feb 12, 4:10 PM ET

Heffernan Michael Thomas 4

4 · COLLEGIUM PHARMACEUTICAL, INC · Filed Feb 12, 2025

Insider Transaction Report

Form 4
Period: 2025-02-10
Transactions
  • Award

    Common Stock

    2025-02-10+4,82050,328 total
Footnotes (1)
  • [F1]Reflects the grant of fully-vested restricted stock units ("RSUs") granted as compensation for the Reporting Person's service as interim Chief Executive Officer in 2024. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES